News

The DENOVOSS Consortium has been granted an EIC Transition grant! In this project, four partners are working together to bring fully engineered but decellularized human cartilage up to clinical standards: Lund University, Dhalion Biotech, Nantes University, and Basel University. We are particularly excited to see Dhalion Biotech significantly extending its portfolio, with the aim to deliver OssiGel as a brand-new class of biomaterial for bone repair.

After receiving both the ERC Proof-of-Concept and the Swedish Research Council grants, we end 2025 on a very high note, with Paul also being granted the ERC Consolidator for his project 'ImmunhOss'. And what better way to celebrate this important milestone for the entire lab than a champagne shower!